Neoplasm
Showing 1 - 25 of 105
Tumor, Caregivers Trial run by the National Institutes of Health Clinical Center (CC) (Sham VR, Active VR)
Not yet recruiting
- Neoplasm
- Caregivers
- Sham VR
- Active VR
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 26, 2023
Tumor Trial in Quebec (SAR444200, Cemiplimab)
Recruiting
- Neoplasm
- SAR444200
- Cemiplimab
-
Providence, Rhode Island
- +3 more
Oct 17, 2022
Cancer, Tumor Trial in Frankfurt (NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51)
Completed
- Cancer
- Neoplasm
- NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51
-
Frankfurt, GermanyKrankenhaus Nordwest
Oct 3, 2022
Samples From People With Unanticipated Response, Significant
Enrolling by invitation
- Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Tumor, Solid Tumors Trial in Camperdown, Liverpool (HS-10241)
Completed
- Neoplasm
- Solid Tumors
-
Camperdown, New South Wales, Australia
- +1 more
Jul 18, 2022
Tumor Trial (Tusamitamab ravtansine)
Not yet recruiting
- Neoplasm
- Tusamitamab ravtansine
- (no location specified)
Jun 22, 2022
Specimen Banking for People With Tumors of Central Nervous
Recruiting
- Brain Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 7, 2022
Tumor Trial in Houston (SGT-53, Topotecan, Cyclophosphamide)
Suspended
- Neoplasm
- SGT-53
- +2 more
-
Houston, TexasTexas Children's Hospital
Feb 7, 2022
Barrett's Esophagus and Early Esophageal Cancer
Terminated
- Barrett Esophagus
- +4 more
- CSA System (CryoSpray AblationTM System)
- CryoSpray Ablation
-
Baltimore, MarylandUniversity of Maryland School of Medicine and Greenebaum Cancer
Jan 25, 2022
Cancer, Tumor Metastasis, Radiation Oncology Trial run by the NCI (Radiation Therapy, ECI301)
Terminated
- Cancer
- +4 more
- Radiation Therapy
- ECI301
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 30, 2021
Drug Interactions Before Antitumor Treatment Initiation
Active, not recruiting
- Neoplasm
-
Paris, FranceAPHP -Cochin Hospital and Georges Pompidou European Hospital
Dec 20, 2021
Patients Who Have Received Gene Therapy Or Gene Marked Products
Recruiting
- Severe Combined Immunodeficiency
- +4 more
- Venipuncture
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Dec 10, 2021
Tumor, Skull Base Tumor Trial in New York (5-Aminolevulinic acid Hydrochloride)
Recruiting
- Neoplasm
- Skull Base Neoplasm
- 5-Aminolevulinic acid Hydrochloride
-
New York, New York
- +2 more
Oct 28, 2021
Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)
Recruiting
- Cancer
- +3 more
- Panitumumab
- +32 more
-
Amersfoort, Utrecht, Netherlands
- +34 more
Oct 26, 2021
Tumor Trial in Worldwide (PF-05212384 (gedatolisib), Docetaxel, Cisplatin)
Completed
- Neoplasm
- PF-05212384 (gedatolisib)
- +3 more
-
Birmingham, Alabama
- +28 more
Sep 9, 2021
Tumor Trial in Tampa (TBCCN-developed educational materials, NCI-developed educational materials)
Completed
- Neoplasm
- TBCCN-developed educational materials
- NCI-developed educational materials
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 17, 2021
Family and Personal History of Malignancy in Intraductal
Completed
- Pancreatic Cancer
- Neoplasm
-
New York, New YorkColumbia University Irving Medical Center
Jul 2, 2021
Sepsis, Septic Shock, Tumor Trial in Amman (Procalcitonin Levels, Control)
Recruiting
- Sepsis
- +3 more
- Procalcitonin Levels
- Control
-
Amman, JordanKing Hussein Cancer Center
Feb 17, 2021